Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).

A. Nardone; Elizbeth Miller

doi:10.2807/esm.09.04.00456-en

Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).

A. Nardone^*, Elizbeth Miller

^*Corresponding author for this work

Pillar Testing Staff budget centre

Research output: Contribution to journal › Article › peer-review

33 Citations (Scopus)

Abstract

Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.

Original language	English
Pages (from-to)	5-7
Number of pages	3
Journal	Eurosurveillance
Volume	9
Issue number	4
DOIs	https://doi.org/10.2807/esm.09.04.00456-en
Publication status	Published - Apr 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2807/esm.09.04.00456-en

Cite this

@article{01e29a53b468463f8a4bff629774eb4a,

title = "Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).",

abstract = "Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.",

author = "A. Nardone and Elizbeth Miller",

year = "2004",

month = apr,

doi = "10.2807/esm.09.04.00456-en",

language = "English",

volume = "9",

pages = "5--7",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "4",

}

TY - JOUR

T1 - Serological surveillance of rubella in Europe

T2 - European Sero-Epidemiology Network (ESEN2).

AU - Nardone, A.

AU - Miller, Elizbeth

PY - 2004/4

Y1 - 2004/4

N2 - Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.

AB - Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.

UR - http://www.scopus.com/inward/record.url?scp=7944227216&partnerID=8YFLogxK

U2 - 10.2807/esm.09.04.00456-en

DO - 10.2807/esm.09.04.00456-en

M3 - Article

C2 - 15192256

AN - SCOPUS:7944227216

SN - 1025-496X

VL - 9

SP - 5

EP - 7

JO - Eurosurveillance

JF - Eurosurveillance

IS - 4

ER -

Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this